Vasectomy reversal outcomes in men after testosterone therapy

Jasper C. Bash, Jamie O. Lo, Akash A. Kapadia, Malachi Mason, Jason C. Hedges

Research output: Contribution to journalArticlepeer-review

1 Scopus citations


The prevalence of males on testosterone therapy (TT) seeking vasectomy reversal (VR) is rising. As medical therapy (MT) to recover spermatogenesis after TT has been previously described, our study’s objective is to present our institution’s management and outcomes of VR in men previously on TT. We performed a retrospective case series of vasectomy patients on TT with subsequent VR by a single microsurgeon between March, 2010 and March, 2022. 14 men undergoing VR during the study period met inclusion criteria. The median age at VR was 43 years with a median obstructive interval of 11 years. Median time from MT to VR was 5 months. Post-operative semen analysis was performed in 10 men and all demonstrated patency. 2 patients had very low sperm counts secondary to continuing TT following VR contrary to medical advice and 5 men with patency achieved pregnancy. Our study noted a high rate of vasovasostomy (VV) (96%) and sustained patency despite a 12-year median obstructive interval. Our findings support favorable outcomes with less stringent VV indications after MT in patients previously on TT that desire VR. The use of MT reduces the recommended wait times for VR after TT discontinuation by more than half.

Original languageEnglish (US)
Article number19496
JournalScientific Reports
Issue number1
StatePublished - Dec 2022

ASJC Scopus subject areas

  • General


Dive into the research topics of 'Vasectomy reversal outcomes in men after testosterone therapy'. Together they form a unique fingerprint.

Cite this